Goldman Sachs’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $146K | Sell |
36,368
-42,740
| -54% | -$172K | ﹤0.01% | 4810 |
|
|
2025
Q1 | $275K | Sell |
79,108
-11,793
| -13% | -$40.9K | ﹤0.01% | 4555 |
|
|
2024
Q4 | $598K | Buy |
90,901
+14,150
| +18% | +$93.1K | ﹤0.01% | 4198 |
|
|
2024
Q3 | $694K | Buy |
76,751
+49,898
| +186% | +$451K | ﹤0.01% | 3953 |
|
|
2024
Q2 | $431K | Buy |
26,853
+3,294
| +14% | +$52.8K | ﹤0.01% | 4031 |
|
|
2024
Q1 | $369K | Buy |
+23,559
| New | +$369K | ﹤0.01% | 4109 |
|